TABLE 1.
Case Number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
---|---|---|---|---|---|---|---|---|
Sex/age | F/67 | M/63 | M/43 | M/38 | M/68 | M/50 | F/29 | M/39 |
Illness (days) | 4 | 6 | 8 | 10 | 16 | 16 | 18 | 20 |
DAD, acute | + | + | + | + | + | + | + | + |
% | 2 | 4 | 3 | 3 | 1 | 1 | 3 | 1 |
grade | 2 | 3 | 2 | 1 | 1 | 1 | 3 | 3 |
Airspace edema | + | + | + | + | + | − | − | − |
% | 3 | 4 | 3 | 4 | 2 | − | − | − |
grade | 2 | 2 | 3 | 2 | 2 | − | − | − |
Bronchiolar fibrin | + | − | + | + | − | − | − | − |
DAD, organizing | − | + | − | − | − | + | + | + |
% | − | 1 | − | − | − | 4 | 4 | 4 |
grade | − | 1 | − | − | − | 3 | 3 | 3 |
Pneumocyte hyperplasia | − | + | − | − | + | + | + | + |
% | − | 2 | − | − | 1 | 4 | 3 | 4 |
grade | − | 3 | − | − | 1 | 2 | 3 | 2 |
Squamous metaplasia | − | + | − | − | + | + | + | + |
Multinucleated cells | − | + | − | − | − | + | + | + |
Acute bronchopneumonia | − | + | − | − | + | + | + | + |
% | − | 2 | − | − | 3 | 4 | 2 | 4 |
grade | − | 1 | − | − | 1 | 3 | 2 | 3 |
Infarct | − | − | − | − | − | + | + | − |
% | − | − | − | − | − | 1 | 1 | − |
Hemorrhage | + | − | − | + | + | + | + | + |
% | 2 | − | − | 2 | 1 | 3 | 2 | 3 |
Fibrin thrombi | − | + | + | − | − | + | + | + |
Cytopathic effect | − | − | − | − | − | − | − | − |
Hemophagocytosis | − | − | − | − | − | − | − | − |
Special stains | − | + | − | − | − | + | − | − |
Viral immunos | − | − | − | − | − | − | − | − |
%: 1 = 1 − 24%, 2 = 25 − 49%, 3 = 50 − 74%, 4 =75 − 100% parenchymal involvement.
Grade: 1 = mild, 2 = moderate, 3 = marked.